About Us

Pharmova is born out of a combination of ‘Pharma’ and ‘Nova’ (New) and Jubilant Pharmova Limited will continue to focus on offering products and services with, excellence in research and manufacturing, catering to the unmet health needs at an affordable price.

It is an integrated global pharmaceuticals company having three business segments Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs.

Pharmaceuticals business through Jubilant Pharma Limited is engaged in manufacturing and supply of Radiopharmaceuticals with a network of 49 Radiopharmacies in the US, Allergy Therapy Products, Contract Manufacturing of Sterile Injectables and Non-sterile products, Active Pharmaceutical Ingredients and Solid Dosage Formulations through six USFDA approved manufacturing facilities in the US, Canada and India.

Contract Research and Development Services business represented by Jubilant Biosys Limited provides innovation and collaborative research to global pharmaceutical innovators through two world-class research centers in Bengaluru and Noida in India.

Proprietary Novel Drugs business through Jubilant Therapeutics Inc. is an innovative patient-centric biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders.

Business Segments

Pharmaceuticals

Jubilant Pharma Limited is engaged in manufacturing and supply of Radiopharmaceuticals with a network of 49 Radiopharmacies in the US, Allergy Therapy

Contract Research and Development Services

Jubilant Biosys Limited provides innovation and collaborative research to global pharmaceutical innovators through…

Proprietary Novel Drugs

Jubilant Therapeutics Inc. is an innovative patient-centric biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders.…

 

Share Prices

Latest News

  • Jubilant Pharmova – Q4 & FY21 Results

    The Board of Jubilant Pharmova Limited met today to approve financial results for the quarter ended March 31, 2021.

Latest News

Jubilant Share Price